- Previous Close
0.1745 - Open
0.1760 - Bid 0.2040 x 300
- Ask 0.2040 x 200
- Day's Range
0.1732 - 0.2380 - 52 Week Range
0.1640 - 99.0000 - Volume
6,149,669 - Avg. Volume
6,376,289 - Market Cap (intraday)
2.962M - Beta (5Y Monthly) -0.30
- PE Ratio (TTM)
-- - EPS (TTM)
-58.2000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
glucotrack.comRecent News: GCTK
View MorePerformance Overview: GCTK
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GCTK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GCTK
View MoreValuation Measures
Market Cap
2.27M
Enterprise Value
4.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-204.31%
Return on Equity (ttm)
-1,943.32%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-14.91M
Diluted EPS (ttm)
-58.2000
Balance Sheet and Cash Flow
Total Cash (mrq)
346k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-6.55M